▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Aflac Q3 20 Earnings Conference Call At 9:00 AM ET

By RTTNews Staff Writer ✉ | Published: 10/28/2020 8:00 AM ET

Aflac Inc. (AFL) will host a conference call at 9:00 AM ET on Oct. 28, 2020, to discuss Q3 20 earnings results.

To access the live webcast, log on to http://investors.aflac.com

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2021

Biotech Stocks Facing FDA Decision In June 2021

Biotech Stocks Facing FDA Decision In April 2021 Lung cancer PDUFA Keytruda HIV COVID 19

Biotech Stocks Facing FDA Decision In April 2021

New Drugs Approved In December

New Drugs Approved In December

Latest Updates on COVID-19

Biden's Goal Of Vaccinating 70% Of U.S. Adults 30+ Achieved: White House

COVID Cases And Deaths At Lowest Levels Since Start Of Pandemic: White House

US Announces Global Allocation Plan For 55 Million COVID Vaccine Doses

Supreme Court Dismisses Challenge To Affordable Care Act

Theravance Phase 2 Nezulcitinib Study Did Not Meet Primary Goal In Acute Lung Injury Due To COVID-19

Read More

COVID-19: Drugs in Development

RELATED NEWS

AFLAC Inc Q1 adjusted earnings Beat Estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Apple Tower Theatre To Open Tomorrow In LA

Bea Lydecker's Recalls Living Free Dietary Supplement Products

Morgan Stanley To Block Unvaccinated Employees, Clients From NY Offices

Prairie Wolf Distillery Hand Sanitizer Recalled

Pradaxa Gets FDA Approval As First Oral Blood Thinning Medication For Children

Amazon Prime Day 2021 Is Here

EU Probing Google On Possible Violation Of Competition Rules In "ad Tech" Supply Chain - Quick Facts

Nokia Offers Flexible Work Time For Employees Post COVID-19

American Airlines Cancels Flights For Bad Weather, Staff Shortage

51job To Be Taken Private In Transaction Valued At $5.7 Bln - Quick Facts

Priceline's Freedom Sale Offer Savings On Travel Deals

Cuisine Solutions Recalls JUST Egg Flavored Plant-based Bites

Orphazyme Gets CRL From FDA On Arimoclomol For Niemann-Pick Disease Type C; Updates FY21 Loss View

Capita And Cabinet Office To Sell AXELOS To PeopleCert

Smiths Medical Recalls Certain Jelco Hypodermic Insulin Syringes

BioNTech Doses First Patient In BNT111 Phase 2 Cancer Vaccine Trial

FDA Approves Bayer's Nonprescription, Nasal Antihistamine

Repare Therapeutics: Fighting Cancer With Synthetic Lethality

L Brands Files Form 10 With SEC For Separation Of Victoria's Secret Business - Quick Facts

EC Approves Sanofi's Aubagio For Treatment Of Pediatric Patients With RRMS

Moderna Commits To Hiring At Least 155 New Massachusetts-based Employees

Pre-market Movers: ACST, TENX, GMTX, EYES…

RedHill Biopharma Presents Positive Oral Opaganib Phase 2 Data In COVID-19

National Express Buys Spain's Transportes Rober For EUR 13 Mln; Says Trading Slightly Ahead Of View

Prairie Wolf Distillery Hand Sanitizer Recalled

Mondi Approves €125 Mln Capital Investment Project At Semi-chemical Fluting Mill In Kuopio

AeroCentury Says Files Proposed Plan Of Reorganization

PerkinElmer To Buy SIRION Biotech

Pear Therapeutics To Become Public Company Through Merger With Thimble Point

EU Probing Google On Possible Violation Of Competition Rules In "ad Tech" Supply Chain - Quick Facts

NetApp Buys Data Mechanics; Terms Not Disclosed - Quick Facts

Medtronic Gets FDA Expanded Approval For Arctic Front Family Of Cardiac Cryoablation Catheters

51job To Be Taken Private In Transaction Valued At $5.7 Bln - Quick Facts

Tonix Pharma Plans To Develop TNX-102 SL For Treatment Of Long COVID Syndrome

Moderna Commits To Hiring At Least 155 New Massachusetts-based Employees

Telecom Plus Stock Down On Weak FY Profit, Maintains Dividend; Sees Higher Adj. Profit In New Year